Impact of acute ischemic stroke treatment in patients >80 years of age: The specialized program of translational research in acute stroke (SPOTRIAS) consortium experience

Stroke

Volumn 43, Issue 9, 2012, Pages 2369-2375

  Willey, Joshua Z ^a   Ortega Gutierrez, Santiago ^a   Petersen, Nils ^a   Khatri, Pooja ^b   Ford, Andria L ^c   Rost, Natalia S ^d   Ali, Latisha K ^e   Gonzales, Nichole R ^f   Merino, Jose G ^g   Meyer, Brett C ^h   Marshall, Randolph S ^a  

^a Och Spine at New York Presbyterian Hospitals   (United States)

^b UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^c WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d MASSACHUSETTS GENERAL HOSPITAL   (United States)

^e UNIVERSITY OF CALIFORNIA   (United States)

^f UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

^g NATIONAL INSTITUTES OF HEALTH   (United States)

^h UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

acute Rx; acute stroke; interventional neuroradiology

Indexed keywords

ALTEPLASE;

AGED; ARTICLE; BRAIN ISCHEMIA; ENDOVASCULAR SURGERY; FEMALE; HUMAN; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; MORTALITY; PRIORITY JOURNAL; PROSPECTIVE STUDY; RETROSPECTIVE STUDY;

AGE FACTORS; AGED; AGED, 80 AND OVER; BRAIN ISCHEMIA; DATA INTERPRETATION, STATISTICAL; ENDOVASCULAR PROCEDURES; FIBRINOLYTIC AGENTS; HOSPITAL MORTALITY; HUMANS; INJECTIONS, INTRA-ARTERIAL; INJECTIONS, INTRAVENOUS; MIDDLE AGED; PROSPECTIVE STUDIES; RETROSPECTIVE STUDIES; RISK; STROKE; THROMBOLYTIC THERAPY; TISSUE PLASMINOGEN ACTIVATOR; TRANSLATIONAL MEDICAL RESEARCH;

EID: 84865603561     PISSN: 00392499     EISSN: 15244628     Source Type: Journal    
DOI: 10.1161/STROKEAHA.112.660993     Document Type: Article

References (33)

1. Rosamond W, Flegal K, Furie K, Go A, Greenlund K, Haase N, et al. Heart disease and stroke statistics\-2008 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation. 2008;117:e25-e146.
2. Lindley RI, Wardlaw JM, Sandercock PA. Thrombolysis in elderly people. Observational data insufficient to change treatment. BMJ. 2011; 342:d306; author reply d312.
3. Fonarow GC, Smith EE, Saver JL, Reeves MJ, Bhatt DL, Grau-Sepulveda MV, et al. Timeliness of tissue-type plasminogen activator therapy in acute ischemic stroke: patient characteristics, hospital factors, and outcomes associated with door-to-needle times within 60 minutes. Circulation. 2011;123:750-758.
4. Hacke W, Kaste M, Bluhmki E, Brozman M, Davalos A, Guidetti D, et al. Thrombolysis with alteplase 3 to 4.5 hours after acute ischemic stroke. N Engl J Med. 2008;359:1317-1329.
5. Furlan A, Higashida R, Wechsler L, Gent M, Rowley H, Kase C, et al. Intra-arterial prourokinase for acute ischemic stroke. The PROACT II study: a randomized controlled trial. Prolyse in Acute Cerebral Thromboembolism. JAMA. 1999;282:2003-2011.
6. van Oostenbrugge RJ, Hupperts RM, Lodder J. Thrombolysis for acute stroke with special emphasis on the very old: experience from a single Dutch centre. J Neurol Neurosurg Psychiatry. 2006;77:375-377.
7. Engelter ST, Bonati LH, Lyrer PA. Intravenous thrombolysis in stroke patients of > or =80 versus <80 years of age\-a systematic review across cohort studies. Age Ageing. 2006;35:572-580.
8. Simon JE, Sandler DL, Pexman JH, Hill MD, Buchan AM. Is intravenous recombinant tissue plasminogen activator (rtPA) safe for use in patients over 80 years old with acute ischaemic stroke? The Calgary experience. Age Ageing. 2004;33:143-149.
9. Berrouschot J, Rother J, Glahn J, Kucinski T, Fiehler J, Thomalla G. Outcome and severe hemorrhagic complications of intravenous thrombolysis with tissue plasminogen activator in very old (> or =80 years) stroke patients. Stroke. 2005;36:2421-2425.
10. Mouradian MS, Senthilselvan A, Jickling G, McCombe JA, Emery DJ, Dean N, et al. Intravenous rtPA for acute stroke: comparing its effectiveness in younger and older patients. J Neurol Neurosurg Psychiatry. 2005;76:1234-1237.
11. Meretoja A, Putaala J, Tatlisumak T, Atula S, Artto V, Curtze S, et al. Off-label thrombolysis is not associated with poor outcome in patients with stroke. Stroke. 2010;41:1450-1458.
12. Bhatnagar P, Sinha D, Parker RA, Guyler P, O'Brien A. Intravenous thrombolysis in acute ischaemic stroke: a systematic review and metaanalysis to aid decision making in patients over 80 years of age. J Neurol Neurosurg Psychiatry. 2011;82:712-717.
13. Chen CI, Iguchi Y, Grotta JC, Garami Z, Uchino K, Shaltoni H, et al. Intravenous tPA for very old stroke patients. Eur Neurol. 2005;54: 140-144.
14. Engelter ST, Reichhart M, Sekoranja L, Georgiadis D, Baumann A, Weder B, et al. Thrombolysis in stroke patients aged 80 years and older: Swiss survey of IV thrombolysis. Neurology. 2005;65:1795-1798.
15. Toni D, Lorenzano S, Agnelli G, Guidetti D, Orlandi G, Semplicini A, et al. Intravenous thrombolysis with rtPA in acute ischemic stroke patients aged older than 80 years in Italy. Cerebrovasc Dis. 2008;25:129-135.
16. Zeevi N, Chhabra J, Silverman IE, Lee NS, McCullough LD. Acute stroke management in the elderly. Cerebrovasc Dis. 2007;23:304-308.
17. Sylaja PN, Dong W, Grotta JC, Miller MK, Tomita K, Hamilton S, et al. Safety outcomes of alteplase among acute ischemic stroke patients with special characteristics. Neurocrit Care. 2007;6:181-185.
18. Ringleb PA, Schwark C, Kohrmann M, Kulkens S, Juttler E, Hacke W, et al. Thrombolytic therapy for acute ischaemic stroke in octogenarians: selection by magnetic resonance imaging improves safety but does not improve outcome. J Neurol Neurosurg Psychiatry. 2007;78:690-693.
19. De Keyser J, Gdovinova Z, Uyttenboogaart M, Vroomen PC, Luijckx GJ. Intravenous alteplase for stroke: beyond the guidelines and in particular clinical situations. Stroke. 2007;38:2612-2618.
20. Mishra NK, Ahmed N, Andersen G, Egido JA, Lindsberg PJ, Ringleb PA, et al. Thrombolysis in very elderly people: controlled comparison of SITS International Stroke Thrombolysis Registry and Virtual International Stroke Trials Archive. BMJ. 2010;341:c6046.
21. Tissue plasminogen activator for acute ischemic stroke. The National Institute of Neurological Disorders and Stroke rtPA stroke study group. N Engl J Med. 1995;333:1581-1587.
22. Generalized efficacy of tPA for acute stroke. Subgroup analysis of the NINDS tPA stroke trial. Stroke. 1997;28:2119-2125.
23. Nogueira RG, Liebeskind DS, Sung G, Duckwiler G, Smith WS. Predictors of good clinical outcomes, mortality, and successful revascularization in patients with acute ischemic stroke undergoing thrombectomy: pooled analysis of the Mechanical Embolus Removal in Cerebral Ischemia (MERCI) and Multi MERCI trials. Stroke. 2009;40:3777-3783.
24. Qureshi AI, Suri MF, Georgiadis AL, Vazquez G, Janjua NA. Intra-ar-terial recanalization techniques for patients 80 years or older with acute ischemic stroke: pooled analysis from 4 prospective studies. AJNR Am J Neuroradiol. 2009;30:1184-1189.
25. Mazighi M, Labreuche J, Meseguer E, Serfaty JM, Laissy JP, Lavallee PC, et al. Impact of a combined intravenous/intra-arterial approach in octogenarians. Cerebrovasc Dis. 2011;31:559-565.
26. Kim D, Ford GA, Kidwell CS, Starkman S, Vinuela F, Duckwiler GR, et al. Intra-arterial thrombolysis for acute stroke in patients 80 and older: a comparison of results in patients younger than 80 years. AJNR Am J Neuroradiol. 2007;28:159-163.
27. Sacco RL, DeRosa JT, Haley EC Jr, Levin B, Ordronneau P, Phillips SJ, et al. Glycine antagonist in neuroprotection for patients with acute stroke: GAIN Americas: a randomized controlled trial. JAMA. 2001;285: 1719-1728.
28. Di Carlo A, Lamassa M, Pracucci G, Basile AM, Trefoloni G, Vanni P, et al. Stroke in the very old: clinical presentation and determinants of 3-month functional outcome: a European perspective. European biomed study of stroke care group. Stroke. 1999;30:2313-2319.
29. Knoflach M, Matosevic B, Rucker M, Furtner M, Mair A, Wille G, et al. Functional recovery after ischemic stroke\-a matter of age: data from the Austrian stroke unit registry. Neurology. 2012;78:279-285.
30. Sharma JC, Fletcher S, Vassallo M. Strokes in the elderly\-higher acute and 3-month mortality\-an explanation. Cerebrovasc Dis. 1999;9:2-9.
31. Liebeskind DS. Collateral circulation. Stroke. 2003;34:2279-2284.
32. Ford GA, Ahmed N, Azevedo E, Grond M, Larrue V, Lindsberg PJ, et al. Intravenous alteplase for stroke in those older than 80 years old. Stroke. 2010;41:2568-2574.
33. Mono ML, Romagna L, Jung S, Arnold M, Galimanis A, Fischer U, et al. Intra-arterial thrombolysis for acute ischemic stroke in octogenarians. Cerebrovasc Dis. 2012;33:116-122.